Case report · 9 Jan 2017
Conference abstractPublished 5 Oct 2018
Hormone replacement therapy really protects a woman against myocardial infarction
University of Oradea, Romania
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objective: The most important objective of this presentation is to put into the discussion this important topic of the hormonal therapy replacement if really protect a woman against heart attack? We know that a woman is naturally protected from estrogenic hormones during her period of menstrual cycles against atherosclerosis, ischemic cardiopathy, and myocardial infarction. During menopause, because menstrual cycles disappear the womanâ??s lost the protection of estrogens hormones for atherosclerosis, ischemic heart disease and the risk of heart attack become high. For this reason, the hope appears from the hormonal therapy replacement after menopause, which develops the idea that if a woman follows the therapy with estrogens hormones or a combination between estrogens and progesterone hormones will be possible to protect against atherosclerosis, ischemic heart disease, and heart attack. The most important question is that this therapy is really safe and with benefits for the womanâ??s patients? Material and Methods: Present the situation of a woman patient, in menopause from four years ago, when started the estrogens hormonal therapy replacement with Estradiol 1 pill/day. After this period of time, she came at the consultation with constrictive chest pain as a claw, 10 minutes duration, which stopped immediately after 1 drug of nitroglycerin administration under the tongue. The EKG registered during crises of chest pain shown ischemic lesion changes in anterior leads. Also, the patient presented the apparition of a nodule in the left breast. This appears after hormonal therapy replacement. Results and Discussions: The most important question persist: deserve a woman during menopause to follow the hormonal therapy replacement for protection against atherosclerosis and ischemic heart disease? The presentation of this case shows, that the ischemic heart disease appears under estrogens therapy replacement and more than that, dangerous side effects appearsâ?? nodule inside of the left breast. Conclusion: The most important conclusion of this presentation is that the hormonal therapy replacement started with all good intentions for the womanâ??s patients isnâ??t safe, because the evolution of atherosclerosis process persist and ischemic heart disease advance during this therapy and more than that with price of dangerous side effects-like apparition of a nodule in the breast. The practice proved that the therapy isnâ??t safe.
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Mini review · 30 Jan 2024
Cardio Protective Mechanisms against Reperfusion Injury in Acute Myocardial Infarction: Targeting Angiotensin II Receptors
Conference abstract · 14 May 2018
Protective effect of anti-HMGB1 protein in experimental myocardial infarction
Conference abstract · 14 Apr 2014
Ticagrelor, but not clopidogrel, protects the heart and limits myocardial infarct size
Review article · 2013
Liver-Mediated Myocardial Protection in Experimental Myocardial Infarction
More from this journal
The newest in Cardiovascular Diseases & Diagnosis.
Article · 19 Feb 2026
When Myxoma Meets Bicuspid Aortic Valve: A Rare and Unexpected Cardiac Association
Brief report · 29 Dec 2025
AI Transforms Cardiology: Diagnosis to Personalized Care
Brief report · 29 Dec 2025
Minimally Invasive Cardiac Surgery: Advancements and Outcomes
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCardiovascular Diseases & Diagnosis
- SubjectCardiology
- BylineArticles whose byline prints “Manuela Stoicescu”

